State Flexibility and Patient Choice Act of 2019
A BILL
To amend the Patient Protection and Affordable Care Act to streamline the State innovation waiver process, and for other purposes.
2. Streamlining the State innovation waiver process
“(2) Budgetary effect
“(A) In general—In determining whether a State plan submitted under subsection (a) meets the deficit neutrality requirements of paragraph (1)(D), the Secretary shall take into consideration the direct budgetary effect of the provisions of such plan on sources of Federal funding other than the funding described in subsection (a)(3).”
“(i) Laws—A law”
“(ii) Certifications—A certification described in this paragraph is a document, signed by the Governor of the State, that certifies that such Governor has the authority under existing State law to take action under this section, including implementation of the State plan under subsection (a)(1)(B).”
“(i) repealing the law described in subparagraph (A)(i); or
“(ii) terminating the certification described in subparagraph (A)(ii), through a certification for such termination signed by the Governor of the State.”
“(3) Expedited determination
“(A) In general—With respect to any application under subsection (a)(1) submitted on or after the date of the enactment of this paragraph, the Secretary shall make a determination on such application, using the criteria for approval otherwise applicable under this section, not later than 60 days after the receipt of such application and shall allow the public notice and comment at the State and Federal levels described under subsection (a)(4) to occur concurrently if such State application—
“(i) is submitted in response to an urgent situation, with respect to areas in the State that the Secretary determines are at risk for substantial increases in premium rates or having no health plans offered in the applicable health insurance market for the current or following plan year; or
“(ii) is for a waiver that is the same or substantially similar to a waiver that the Secretary already has approved for another State.
“(B) Approval limitations for urgent situations
“(i) Provisional approval—A waiver approved under the expedited determination process under subparagraph (A)(i) may extend over a period of not longer than 3 years.
“(ii) Full approval—Subject to the requirements for approval otherwise applicable under this section, not later than 1 year before the expiration of a provisional waiver period described in clause (i) with respect to an application described in subparagraph (A)(i), the Secretary shall make a determination on whether to extend the term of such waiver for longer than the period described in clause (i), for a total waiver term not to exceed 6 years. The Secretary may request additional information as the Secretary determines appropriate to make such determination.
“(C) GAO study—Not later than 5 years after the date of enactment of the State Flexibility and Patient Choice Act of 2019, the Comptroller General of the United States shall conduct a review of all waivers approved pursuant to an application under subparagraph (A)(ii) to evaluate whether such waivers met the requirements of subsection (b)(1) and whether the applications should have qualified for such an expedited determination.”
“(f) Additional provisions—In carrying out this section, the Secretary shall—
“(1) issue guidance, not later than 30 days after the date of the enactment of this subsection, that includes initial examples of model State plans that may meet the requirements for approval under this section; and
“(2) periodically review the guidance issued under paragraph (1) and, when appropriate, issue additional examples of model State plans that may meet the requirements for approval under this section, which may include—
“(A) model plans establishing reinsurance or invisible high-risk pool arrangements for purposes of covering the cost of high-risk individuals;
“(B) model plans expanding insurer participation, access to affordable health plans, network adequacy, and health plan options over the entire applicable health insurance market in the State;
“(C) model plans that encourage or require health plans in a State to deploy value-based insurance designs which structure enrollee cost-sharing and other health plan design elements to encourage enrollees to consume high-value clinical services;
“(D) model plans allowing for significant variation in health plan benefit design; or
“(E) any other model plan determined appropriate by the Secretary.”